Logo image of VRTS

VIRTUS INVESTMENT PARTNERS (VRTS) Stock Fundamental Analysis

NYSE:VRTS - New York Stock Exchange, Inc. - US92828Q1094 - Common Stock - Currency: USD

181.68  +5.66 (+3.22%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to VRTS. VRTS was compared to 232 industry peers in the Capital Markets industry. VRTS has only an average score on both its financial health and profitability. VRTS has a decent growth rate and is not valued too expensively. Finally VRTS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year VRTS was profitable.
In the past year VRTS had a positive cash flow from operations.
In the past 5 years VRTS has always been profitable.
Of the past 5 years VRTS 4 years had a positive operating cash flow.
VRTS Yearly Net Income VS EBIT VS OCF VS FCFVRTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

VRTS has a Return On Assets of 3.27%. This is comparable to the rest of the industry: VRTS outperforms 55.17% of its industry peers.
With a decent Return On Equity value of 13.49%, VRTS is doing good in the industry, outperforming 73.28% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.88%, VRTS is in line with its industry, outperforming 48.71% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for VRTS is below the industry average of 7.85%.
The last Return On Invested Capital (3.88%) for VRTS is above the 3 year average (3.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.27%
ROE 13.49%
ROIC 3.88%
ROA(3y)3.19%
ROA(5y)3.43%
ROE(3y)14.36%
ROE(5y)15.89%
ROIC(3y)3.76%
ROIC(5y)4.34%
VRTS Yearly ROA, ROE, ROICVRTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

VRTS has a Profit Margin (13.35%) which is in line with its industry peers.
In the last couple of years the Profit Margin of VRTS has declined.
The Operating Margin of VRTS (20.14%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of VRTS has declined.
Industry RankSector Rank
OM 20.14%
PM (TTM) 13.35%
GM N/A
OM growth 3Y-17.09%
OM growth 5Y-2.7%
PM growth 3Y-14.2%
PM growth 5Y-2.84%
GM growth 3YN/A
GM growth 5YN/A
VRTS Yearly Profit, Operating, Gross MarginsVRTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The number of shares outstanding for VRTS has been reduced compared to 1 year ago.
Compared to 5 years ago, VRTS has more shares outstanding
VRTS has a worse debt/assets ratio than last year.
VRTS Yearly Shares OutstandingVRTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
VRTS Yearly Total Debt VS Total AssetsVRTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

VRTS has an Altman-Z score of 0.84. This is a bad value and indicates that VRTS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VRTS (0.84) is comparable to the rest of the industry.
VRTS has a debt to FCF ratio of 87.76. This is a negative value and a sign of low solvency as VRTS would need 87.76 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 87.76, VRTS is in line with its industry, outperforming 40.09% of the companies in the same industry.
VRTS has a Debt/Equity ratio of 2.54. This is a high value indicating a heavy dependency on external financing.
VRTS has a worse Debt to Equity ratio (2.54) than 81.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF 87.76
Altman-Z 0.84
ROIC/WACCN/A
WACCN/A
VRTS Yearly LT Debt VS Equity VS FCFVRTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

VRTS has a Current Ratio of 2.05. This indicates that VRTS is financially healthy and has no problem in meeting its short term obligations.
VRTS has a better Current ratio (2.05) than 68.97% of its industry peers.
VRTS has a Quick Ratio of 2.05. This indicates that VRTS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of VRTS (2.05) is better than 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 2.05
VRTS Yearly Current Assets VS Current LiabilitesVRTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.20% over the past year.
The Earnings Per Share has been growing by 12.37% on average over the past years. This is quite good.
Looking at the last year, VRTS shows a small growth in Revenue. The Revenue has grown by 3.84% in the last year.
VRTS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.00% yearly.
EPS 1Y (TTM)15.2%
EPS 3Y-9.8%
EPS 5Y12.37%
EPS Q2Q%5.91%
Revenue 1Y (TTM)3.84%
Revenue growth 3Y-2.52%
Revenue growth 5Y10%
Sales Q2Q%-1.31%

3.2 Future

Based on estimates for the next years, VRTS will show a small growth in Earnings Per Share. The EPS will grow by 2.14% on average per year.
Based on estimates for the next years, VRTS will show a decrease in Revenue. The Revenue will decrease by -2.45% on average per year.
EPS Next Y-4%
EPS Next 2Y-0.63%
EPS Next 3Y2.14%
EPS Next 5YN/A
Revenue Next Year-7.27%
Revenue Next 2Y-4%
Revenue Next 3Y-2.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRTS Yearly Revenue VS EstimatesVRTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
VRTS Yearly EPS VS EstimatesVRTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.81, which indicates a rather cheap valuation of VRTS.
Based on the Price/Earnings ratio, VRTS is valued cheaply inside the industry as 88.36% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of VRTS to the average of the S&P500 Index (26.65), we can say VRTS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.98, the valuation of VRTS can be described as very cheap.
Based on the Price/Forward Earnings ratio, VRTS is valued cheaply inside the industry as 90.95% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.27, VRTS is valued rather cheaply.
Industry RankSector Rank
PE 6.81
Fwd PE 6.98
VRTS Price Earnings VS Forward Price EarningsVRTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VRTS is valued cheaply inside the industry as 81.90% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as VRTS.
Industry RankSector Rank
P/FCF 48.55
EV/EBITDA 13.46
VRTS Per share dataVRTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y-0.63%
EPS Next 3Y2.14%

7

5. Dividend

5.1 Amount

VRTS has a Yearly Dividend Yield of 5.17%, which is a nice return.
Compared to an average industry Dividend Yield of 8.07, VRTS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, VRTS pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.17%

5.2 History

On average, the dividend of VRTS grows each year by 17.66%, which is quite nice.
VRTS has been paying a dividend for at least 10 years, so it has a reliable track record.
VRTS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)17.66%
Div Incr Years7
Div Non Decr Years10
VRTS Yearly Dividends per shareVRTS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

VRTS pays out 50.06% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of VRTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP50.06%
EPS Next 2Y-0.63%
EPS Next 3Y2.14%
VRTS Yearly Income VS Free CF VS DividendVRTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
VRTS Dividend Payout.VRTS Dividend Payout, showing the Payout Ratio.VRTS Dividend Payout.PayoutRetained Earnings

VIRTUS INVESTMENT PARTNERS

NYSE:VRTS (6/24/2025, 11:21:47 AM)

181.68

+5.66 (+3.22%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-24 2025-07-24/bmo
Inst Owners83.57%
Inst Owner Change1.04%
Ins Owners6.15%
Ins Owner Change3.05%
Market Cap1.26B
Analysts46.67
Price Target171.87 (-5.4%)
Short Float %1.5%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 5.17%
Yearly Dividend8.27
Dividend Growth(5Y)17.66%
DP50.06%
Div Incr Years7
Div Non Decr Years10
Ex-Date07-31 2025-07-31 (2.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.4%
Min EPS beat(2)-1%
Max EPS beat(2)3.8%
EPS beat(4)1
Avg EPS beat(4)-0.12%
Min EPS beat(4)-3.1%
Max EPS beat(4)3.8%
EPS beat(8)2
Avg EPS beat(8)-1.59%
EPS beat(12)4
Avg EPS beat(12)-1.43%
EPS beat(16)6
Avg EPS beat(16)-0.52%
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-3.81%
Max Revenue beat(2)-1.95%
Revenue beat(4)0
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-3.81%
Max Revenue beat(4)-1.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.65%
Revenue beat(12)3
Avg Revenue beat(12)0.58%
Revenue beat(16)7
Avg Revenue beat(16)3.89%
PT rev (1m)0%
PT rev (3m)-22.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.87%
Valuation
Industry RankSector Rank
PE 6.81
Fwd PE 6.98
P/S 1.39
P/FCF 48.55
P/OCF 38.63
P/B 1.4
P/tB 9.56
EV/EBITDA 13.46
EPS(TTM)26.68
EY14.69%
EPS(NY)26.03
Fwd EY14.33%
FCF(TTM)3.74
FCFY2.06%
OCF(TTM)4.7
OCFY2.59%
SpS130.66
BVpS129.34
TBVpS19.01
PEG (NY)N/A
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 13.49%
ROCE 5.2%
ROIC 3.88%
ROICexc 4.03%
ROICexgc 5.22%
OM 20.14%
PM (TTM) 13.35%
GM N/A
FCFM 2.86%
ROA(3y)3.19%
ROA(5y)3.43%
ROE(3y)14.36%
ROE(5y)15.89%
ROIC(3y)3.76%
ROIC(5y)4.34%
ROICexc(3y)10.87%
ROICexc(5y)12.89%
ROICexgc(3y)110.04%
ROICexgc(5y)160.56%
ROCE(3y)5.04%
ROCE(5y)5.81%
ROICexcg growth 3Y-77.85%
ROICexcg growth 5Y3.06%
ROICexc growth 3Y-48.2%
ROICexc growth 5Y2.75%
OM growth 3Y-17.09%
OM growth 5Y-2.7%
PM growth 3Y-14.2%
PM growth 5Y-2.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF 87.76
Debt/EBITDA 9.12
Cap/Depr 9.92%
Cap/Sales 0.74%
Interest Coverage 250
Cash Conversion 13.06%
Profit Quality 21.45%
Current Ratio 2.05
Quick Ratio 2.05
Altman-Z 0.84
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)10.41%
Cap/Depr(5y)9.08%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.2%
EPS 3Y-9.8%
EPS 5Y12.37%
EPS Q2Q%5.91%
EPS Next Y-4%
EPS Next 2Y-0.63%
EPS Next 3Y2.14%
EPS Next 5YN/A
Revenue 1Y (TTM)3.84%
Revenue growth 3Y-2.52%
Revenue growth 5Y10%
Sales Q2Q%-1.31%
Revenue Next Year-7.27%
Revenue Next 2Y-4%
Revenue Next 3Y-2.45%
Revenue Next 5YN/A
EBIT growth 1Y20.18%
EBIT growth 3Y-19.18%
EBIT growth 5Y7.03%
EBIT Next Year-4.96%
EBIT Next 3Y-0.99%
EBIT Next 5YN/A
FCF growth 1Y-84.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.05%
OCF growth 3Y-86.19%
OCF growth 5YN/A